Apimeds Pharmaceuticals US, Inc.
AMEXAPUS short interest jumped 20% over the past week to 112,767 shares, though it fell 6.7% in the last session as the stock crashed 35%.
Snapshot as of 9 May 2026
APUS has had a turbulent week — a 60% price spike in three days, a new co-CEO, a major corporate dispute resolved, and short sellers scrambling to add exposure simultaneously. The catalyst behind the move is corporate,…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for APUS — free to start on ORTEX.
Sign up for free →Open APUS on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live APUS data →